ArticleJournal of Korean medical science2021

Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.

Youn Young Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.